Burney Co. Invests $3.26 Million in Envista Holdings Corporation $NVST

Burney Co. acquired a new position in Envista Holdings Corporation (NYSE:NVST) in the first quarter, Holdings Channel.com reports. The institutional investor acquired 128,541 shares of the company’s stock, valued at approximately $3,261,000.

Other large investors have also recently added to or reduced their stakes in the company. Millennium Management LLC boosted its position in Envista by 1,442.7% during the 4th quarter. Millennium Management LLC now owns 2,420,615 shares of the company’s stock worth $52,552,000 after acquiring an additional 2,263,712 shares during the period. Holocene Advisors LP acquired a new position in shares of Envista during the second quarter valued at $43,936,000. Norges Bank acquired a new position in shares of Envista during the fourth quarter valued at $45,113,000. Alliancebernstein L.P. raised its stake in shares of Envista by 34.0% during the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company’s stock valued at $119,164,000 after purchasing an additional 1,547,656 shares in the last quarter. Finally, Freestone Grove Partners LP bought a new stake in shares of Envista during the fourth quarter valued at about $29,046,000.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on NVST shares. Robert W. Baird increased their target price on shares of Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Barclays reduced their price target on shares of Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, June 11th. JPMorgan Chase & Co. increased their price objective on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Citigroup started coverage on shares of Envista in a research note on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective on the stock. Finally, Zacks Research cut Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. Six analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $28.67.

Envista Stock Performance

NYSE:NVST opened at $27.16 on Wednesday. The company has a 50-day moving average of $24.87 and a 200-day moving average of $25.37. The firm has a market cap of $4.42 billion, a price-to-earnings ratio of 66.25, a price-to-earnings-growth ratio of 1.56 and a beta of 0.86. The company has a current ratio of 2.44, a quick ratio of 2.06 and a debt-to-equity ratio of 0.47. Envista Holdings Corporation has a twelve month low of $18.77 and a twelve month high of $30.42.

Envista (NYSE:NVST) last released its earnings results on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. Envista had a net margin of 2.41% and a return on equity of 7.11%. The business had revenue of $705.50 million for the quarter, compared to the consensus estimate of $680.03 million. During the same period in the previous year, the firm earned $0.24 EPS. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Analysts forecast that Envista Holdings Corporation will post 1.42 earnings per share for the current fiscal year.

Envista Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.